Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
The 21st World Congress of Chinese Medicine - Seminar on the Integration of Industry and Education in Cardiovascular and Cerebrovascular Diseases Kicks off in Paris 2024-10-29 11:01
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies 2024-10-29 09:13
Blackmores Celebrates Gold Win with Trusted Brands 2024 2024-10-29 09:00
Innovent Announces Results of a Phase 2 Study of Picankibart (Anti-IL-23p19 Antibody) in Plaque Psoriasis, Showing Efficacy in Patients with Prior Inadequate Response to IL-17 Biologics 2024-10-29 07:57
Asia CEO Awards Adds USANA Philippines to Their Circle of Excellence 2024-10-29 07:47
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY 2024-10-29 06:32
KIND Presents Positive Results of AND017 to Treat Anemia Associated with Chronic Kidney Disease in Two Phase II and Two Phase I 2024-10-29 05:42
Alimetry revolutionises gut health diagnosis by integrating AI into its wearable device, raises US $18m to fuel next phase of growth 2024-10-29 05:08
$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT 2024-10-29 02:00
Ping An Health Collaborates with Industry to Launch China's First "Internet-Based Family Doctor Service Standards" 2024-10-28 21:30
TeleVox Applauded by Frost & Sullivan for Improving Patient Experience through Effective Engagement and Customer Value 2024-10-28 21:00
Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY 2024-10-28 19:03
I-Mab to Participate at the Truist Securities BioPharma Symposium 2024-10-28 19:00
WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development 2024-10-28 17:00
Lilly's Mounjaro® (tirzepatide) Approved in Hong Kong in KwikPen® Presentation for Chronic Weight Management and Type 2 Diabetes, Offering a New Option for the Treatment of Obesity, Overweight and Type 2 Diabetes 2024-10-28 15:12
/C O R R E C T I O N -- Seegene Inc./ 2024-10-28 12:50
DKSH and FrontierView Publish Whitepaper on Southeast Asia as a Growth Accelerator for Global Healthcare Firms 2024-10-28 09:00
PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint 2024-10-28 02:56
RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation 2024-10-26 01:24
KIND Announces FDA Granted Orphan Drug Designation (ODD) for AND017 in the Treatment of Sickle Cell Disease (SCD) 2024-10-26 00:33
1 13 14 15 16 17 1596